PARVB
Beta-parvin
Also known as: CGI-56, PARVB_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HBI1
- Gene
- PARVB
- Ensembl
- ENSG00000188677
- Chromosome
- 22
- Canonical length
- 364 aa
- Protein class
- Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane,Actin filaments
OverviewNCBI Gene
This gene encodes a member of the parvin family of actin-binding proteins, which play a role in cytoskeleton organization and cell adhesion. These proteins are associated with focal contacts and contain calponin homology domains that bind to actin filaments. This family member binds to alphaPIX and alpha-actinin, and it can inhibit the activity of integrin-linked kinase. This protein also functions in tumor suppression. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
364 residues, UniProt reviewed canonical sequence.
>Q9HBI1|PARVB
1 MSSAPRSPTP RPRRMKKDES FLGKLGGTLA RKRRAREVSD LQEEGKNAIN SPMSPALVDV
61 HPEDTQLEEN EERTMIDPTS KEDPKFKELV KVLLDWINDV LVEERIIVKQ LEEDLYDGQV
121 LQKLLEKLAG CKLNVAEVTQ SEIGQKQKLQ TVLEAVHDLL RPRGWALRWS VDSIHGKNLV
181 AILHLLVSLA MHFRAPIRLP EHVTVQVVVV RKREGLLHSS HISEELTTTT EMMMGRFERD
241 AFDTLFDHAP DKLSVVKKSL ITFVNKHLNK LNLEVTELET QFADGVYLVL LMGLLEDYFV
301 PLHHFYLTPE SFDQKVHNVS FAFELMLDGG LKKPKARPED VVNLDLKSTL RVLYNLFTKY
361 KNVELocalizationUniProt · AlphaFold · HPA
Whether an antibody against PARVB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 184 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 184 nTPM
- tongue: 159 nTPM
- heart muscle: 81 nTPM
- bone marrow: 41 nTPM
- adipose tissue: 40 nTPM
- choroid plexus: 40 nTPM
Single-cell type
- megakaryocytes: 1,193 nCPM
- platelets: 752 nCPM
- erythrocyte progenitors: 307 nCPM
- myonuclei: 228 nCPM
- pdcs: 214 nCPM
- mast cells: 212 nCPM
Immune cell
- plasmacytoid DC: 15 nTPM
- total PBMC: 9.5 nTPM
- myeloid DC: 7.2 nTPM
- intermediate monocyte: 7.1 nTPM
- classical monocyte: 6.5 nTPM
- basophil: 6.4 nTPM
Brain region
- cerebral cortex: 67 nTPM
- thalamus: 57 nTPM
- pons: 54 nTPM
- amygdala: 52 nTPM
- midbrain: 51 nTPM
- hypothalamus: 49 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.28
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.1
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin cytoskeleton organization
- cell projection assembly
- establishment or maintenance of cell polarity regulating cell shape
- lamellipodium assembly
- substrate adhesion-dependent cell spreading
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PARVB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PARVB as an antibody target. Whether an autoantibody or antibody against PARVB could matter depends on whether native PARVB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PARVB is annotated at the cell surface, where native PARVB is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PARVB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...